| meta-analysis | Q815382 |
| scholarly article | Q13442814 |
| P50 | author | Gordon Guyatt | Q5585214 |
| Per Olav Vandvik | Q57313206 | ||
| Bradley C Johnston | Q123434367 | ||
| P2093 | author name string | Xin Sun | |
| Joshua Z Goldenberg | |||
| P2860 | cites work | Probiotics for the prevention of pediatric antibiotic-associated diarrhea | Q24245196 |
| The appropriateness of asymmetry tests for publication bias in meta-analyses: a large survey | Q24282603 | ||
| Probiotics in prevention of antibiotic associated diarrhoea: meta-analysis | Q24529831 | ||
| Systematic review and meta-analysis of Saccharomyces boulardii in adult patients | Q24621081 | ||
| What is meant by intention to treat analysis? Survey of published randomised controlled trials | Q24647858 | ||
| What is "quality of evidence" and why is it important to clinicians? | Q24647929 | ||
| LOST to follow-up Information in Trials (LOST-IT): a protocol on the potential impact | Q24652537 | ||
| Effect of a fermented milk combining Lactobacillus acidophilus Cl1285 and Lactobacillus casei in the prevention of antibiotic-associated diarrhea: a randomized, double-blind, placebo-controlled trial | Q24655137 | ||
| The case of the misleading funnel plot | Q24676535 | ||
| Bias in meta-analysis detected by a simple, graphical test | Q24685585 | ||
| Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis | Q27860511 | ||
| Operating characteristics of a rank correlation test for publication bias | Q27860653 | ||
| Measuring inconsistency in meta-analyses | Q27860655 | ||
| Lactobacillus bacteremia, clinical significance, and patient outcome, with special focus on probiotic L. rhamnosus GG | Q28234977 | ||
| Saccharomyces boulardii in the prevention of antibiotic-associated diarrhoea in children: a randomized double-blind placebo-controlled trial | Q28237525 | ||
| Efficacy of probiotics in prevention of acute diarrhoea: a meta-analysis of masked, randomised, placebo-controlled trials | Q28242365 | ||
| Effects of a specially designed fermented milk product containing probiotic Lactobacillus casei DN-114 001 and the eradication of H. pylori in children: a prospective randomized double-blind study | Q28265972 | ||
| Effect of a probiotic infant formula on infections in child care centers: comparison of two probiotic agents | Q28300892 | ||
| Lactobacillus GG in the prevention of antibiotic-associated diarrhea in children | Q29028534 | ||
| Demonstration of safety of probiotics -- a review | Q31956781 | ||
| Meta-analysis: non-pathogenic yeast Saccharomyces boulardii in the prevention of antibiotic-associated diarrhoea | Q33222511 | ||
| Probiotics in the prevention of antibiotic-associated diarrhea in children: a meta-analysis of randomized controlled trials | Q33255725 | ||
| Effect of Lactobacillus GG yoghurt in prevention of antibiotic associated diarrhoea | Q33451610 | ||
| Prophylactic Lactobacillus GG reduces antibiotic-associated diarrhea in children with respiratory infections: a randomized study | Q33878836 | ||
| Meta-analysis: the effect of probiotic administration on antibiotic-associated diarrhoea. | Q33960898 | ||
| Better reporting of harms in randomized trials: an extension of the CONSORT statement | Q33983100 | ||
| Dietary modulation of the human colonic microbiota: updating the concept of prebiotics | Q34015209 | ||
| Role of Lactobacillus in the prevention of antibiotic-associated diarrhea: a meta-analysis | Q34094620 | ||
| Probiotics, prebiotics, and synbiotics--approaching a definition | Q34130884 | ||
| The Use of Probiotics in Gastrointestinal Disease | Q34482754 | ||
| Meta-analysis of probiotics for the prevention of antibiotic associated diarrhea and the treatment of Clostridium difficile disease | Q34517039 | ||
| Lactobacillus reuteri therapy to reduce side-effects during anti-Helicobacter pylori treatment in children: a randomized placebo controlled trial. | Q34572969 | ||
| Antibiotic-Associated Pseudomembranous Colitis Due to Toxin-Producing Clostridia | Q34708067 | ||
| Safety of probiotics that contain lactobacilli or bifidobacteria | Q35081764 | ||
| Safety of probiotics: comparison of two popular strains | Q35128833 | ||
| Does eating yogurt prevent antibiotic-associated diarrhoea? A placebo-controlled randomised controlled trial in general practice | Q36156241 | ||
| Antimicrobial-associated risk factors for Clostridium difficile infection | Q37051298 | ||
| Antibiotic-associated diarrhea: epidemiology, trends and treatment | Q37277087 | ||
| Interpretation of tests of heterogeneity and bias in meta-analysis | Q37329334 | ||
| Safety of probiotics in patients receiving nutritional support: a systematic review of case reports, randomized controlled trials, and nonrandomized trials | Q37678738 | ||
| Measurement issues in trials of pediatric acute diarrheal diseases: a systematic review | Q37766694 | ||
| Risk of bias versus quality assessment of randomised controlled trials: cross sectional study | Q42081186 | ||
| Probiotics for pediatric antibiotic-associated diarrhea: a meta-analysis of randomized placebo-controlled trials | Q42470900 | ||
| Standardising outcomes for clinical trials and systematic reviews | Q42910882 | ||
| The effect of a multispecies probiotic on the intestinal microbiota and bowel movements in healthy volunteers taking the antibiotic amoxycillin | Q43352809 | ||
| Frequency of antibiotic-associated diarrhoea in 2462 antibiotic-treated hospitalized patients: a prospective study | Q43517827 | ||
| Clinical safety of Lactobacillus casei shirota as a probiotic in critically ill children | Q44553242 | ||
| Lactobacillus sepsis associated with probiotic therapy. | Q45012027 | ||
| The probiotic effect of Saccharomyces boulardii in a pediatric age group | Q45051635 | ||
| A double-blind, placebo-controlled study of the efficacy of Lactinex in the prophylaxis of amoxicillin-induced diarrhea | Q45204724 | ||
| Is a subgroup effect believable? Updating criteria to evaluate the credibility of subgroup analyses | Q45356123 | ||
| Randomized, double-blind, placebo-controlled trial: effect of lactobacillus GG supplementation on Helicobacter pylori eradication rates and side effects during treatment in children | Q46069552 | ||
| Bifidobacterium longum PL03, Lactobacillus rhamnosus KL53A, and Lactobacillus plantarum PL02 in the prevention of antibiotic-associated diarrhea in children: a randomized controlled pilot trial. | Q46430840 | ||
| The effects of probiotics on PPI-triple therapy for Helicobacter pylori eradication | Q46456017 | ||
| Effect of a milk formula with prebiotics on the intestinal microbiota of infants after an antibiotic treatment | Q46956158 | ||
| Oral probiotics prevent necrotizing enterocolitis in very low birth weight neonates | Q47370646 | ||
| Prevention of antibiotic-associated diarrhea in children by Clostridium butyricum MIYAIRI. | Q51680807 | ||
| Epidemiology, risk factors and treatments for antibiotic-associated diarrhea | Q52533461 | ||
| A Randomized Formula Controlled Trial of Bifidobacterium lactis and Streptococcus thermophilus for Prevention of Antibiotic-Associated Diarrhea in Infants | Q58227623 | ||
| Spontaneously fermented millet product as a natural probiotic treatment for diarrhoea in young children: An intervention study in Northern Ghana | Q58816519 | ||
| Modulation of the intestinal ecosystem by probiotics and lactulose in children during treatment with ceftriaxone | Q63391480 | ||
| Meningitis caused by Bifidobacterium in an infant | Q67940120 | ||
| Lack of relationship of Clostridium difficile to antibiotic-associated diarrhea in children | Q71081354 | ||
| Lactobacilli and bacteremia in southern Finland, 1989-1992 | Q71644809 | ||
| Probiotics plus antibiotics: regulating our bacterial environment | Q73146491 | ||
| Probiotics and immune response | Q73351190 | ||
| Incidence and risk factors of oral antibiotic-associated diarrhea in an outpatient pediatric population | Q73575423 | ||
| Lactobacillus endocarditis caused by a probiotic organism | Q77664493 | ||
| Are live saccharomyces yeasts harmful to patients? | Q77845608 | ||
| Liver abscess due to a Lactobacillus rhamnosus strain indistinguishable from L. rhamnosus strain GG | Q78144305 | ||
| Prevention of antibiotic-associated diarrhoea by a fermented probiotic milk drink | Q79933005 | ||
| Benefits of oral supplementation with and without synbiotics in young children with acute bacterial infections | Q79955318 | ||
| Probiotic administration and the incidence of nosocomial infection in pediatric intensive care: a randomized placebo-controlled trial | Q80785665 | ||
| Clinical trial: effectiveness of Lactobacillus rhamnosus (strains E/N, Oxy and Pen) in the prevention of antibiotic-associated diarrhoea in children | Q81078669 | ||
| Oral probiotics reduce the incidence and severity of necrotizing enterocolitis in very low birth weight infants | Q81224806 | ||
| Can Saccharomyces boulardii prevent antibiotic-associated diarrhea in children? | Q81431262 | ||
| Saccharomyces boulardii and antibiotic-associated diarrhoea in children | Q81835696 | ||
| A dose dependent impact of prebiotic galactooligosaccharides on the intestinal microbiota of healthy adults | Q82361333 | ||
| A randomized clinical trial measuring the influence of kefir on antibiotic-associated diarrhea: the measuring the influence of Kefir (MILK) Study | Q84342755 | ||
| Proceedings of the International Symposium on Probiotics and Prebiotics. Kiel, Germany, June 11-12, 1998 | Q95788572 | ||
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | antibiotic | Q12187 |
| probiotics | Q1816730 | ||
| diarrhea | Q40878 | ||
| P304 | page(s) | CD004827 | |
| P577 | publication date | 2011-11-09 | |
| P1433 | published in | Cochrane Database of Systematic Reviews | Q15750361 |
| P1476 | title | Probiotics for the prevention of pediatric antibiotic-associated diarrhea |
| Q33618653 | 'Someone should oversee it': patient perspectives on the ethical issues arising with the regulation of probiotics |
| Q36179468 | A gastroenterologist's guide to probiotics |
| Q26771884 | A gastrointestinal anti-infectious biotherapeutic agent: the heat-treated Lactobacillus LB |
| Q58798841 | A practical guide for probiotics applied to the case of antibiotic-associated diarrhea in The Netherlands |
| Q37994645 | A review of the pharmacobiotic regulation of gastrointestinal inflammation by probiotics, commensal bacteria and prebiotics |
| Q46826901 | Acupuncture and Migraine Prophylaxis, Probiotics and C. Difficile-Associated Diarrhea, Preventive Group Counseling and Postpartum Depression, Black Cohosh and Menopausal Symptoms, Deep Needling Electroacupuncture and Trigeminal Neuralgia |
| Q36585052 | An oral preparation of Lactobacillus acidophilus for the treatment of uncomplicated acute watery diarrhoea in Vietnamese children: study protocol for a multicentre, randomised, placebo-controlled trial |
| Q55307054 | An overview on the interplay between nutraceuticals and gut microbiota. |
| Q37712802 | Anti-infective activities of lactobacillus strains in the human intestinal microbiota: from probiotics to gastrointestinal anti-infectious biotherapeutic agents |
| Q35832867 | Bugs and Guts: Practical Applications of Probiotics for Gastrointestinal Disorders in Children |
| Q34981520 | Can probiotic yogurt prevent diarrhoea in children on antibiotics? A double-blind, randomised, placebo-controlled study |
| Q34003398 | Caregivers' knowledge and use of fermented foods for infant and young children feeding in a rural community of odi, gauteng province, South Africa |
| Q37443830 | Combination of probiotics and antibiotics in the prevention of recurrent urinary tract infection in children |
| Q38420867 | Comparison between the standard and a new alternative format of the Summary-of-Findings tables in Cochrane review users: study protocol for a randomized controlled trial |
| Q26752760 | Comparison of pediatric and adult antibiotic-associated diarrhea and Clostridium difficile infections |
| Q35057148 | Decreased plasma myeloperoxidase associated with probiotic therapy in autistic children |
| Q36550380 | Designer foods and their benefits: A review |
| Q42267314 | Differential effect on cell-mediated immunity in human volunteers after intake of different lactobacilli |
| Q90205959 | Efficacy of Lactobacillus rhamnosus GG in treatment of acute pediatric diarrhea: A systematic review with meta-analysis |
| Q37500739 | Efficacy of Synbiotics for Treatment of Bacillary Dysentery in Children: A Double-Blind, Randomized, Placebo-Controlled Study. |
| Q89731185 | Efficacy of probiotics on cognition, and biomarkers of inflammation and oxidative stress in adults with Alzheimer's disease or mild cognitive impairment - a meta-analysis of randomized controlled trials |
| Q47856504 | Frequency of Antibiotic-Associated Diarrhea and Related Complications in Pediatric Patients Who Underwent Hypospadias Repair: a Comparative Study Using Probiotics vs Placebo |
| Q36415190 | Gastrointestinal Microbiota and Some Children Diseases: A Review |
| Q35616074 | Gut microbiome, gut function, and probiotics: Implications for health. |
| Q27001712 | Intestinal microbiota in health and disease: role of bifidobacteria in gut homeostasis |
| Q39369353 | Lactobacilli and bifidobacteria in the prevention of antibiotic-associated diarrhoea and Clostridium difficile diarrhoea in older inpatients (PLACIDE): a randomised, double-blind, placebo-controlled, multicentre trial. |
| Q35998372 | Lactobacillus rhamnosus GG Intake Modifies Preschool Children's Intestinal Microbiota, Alleviates Penicillin-Associated Changes, and Reduces Antibiotic Use. |
| Q26999178 | Microbial ecology and host-microbiota interactions during early life stages |
| Q38016805 | Microbiota-targeted therapies: an ecological perspective |
| Q33742439 | Microorganisms with claimed probiotic properties: an overview of recent literature. |
| Q30570549 | Molecular analysis and clinical significance of Lactobacillus spp. recovered from clinical specimens presumptively associated with disease |
| Q28393272 | Oral microbial profile discriminates breast-fed from formula-fed infants |
| Q26771942 | Part 2: Treatments for Chronic Gastrointestinal Disease and Gut Dysbiosis |
| Q64068584 | Pilot study for the understanding and use of probiotics by different paediatric healthcare professionals working in different European countries |
| Q34423174 | Prebiotics in healthy infants and children for prevention of acute infectious diseases: a systematic review and meta-analysis |
| Q42631832 | Prevention and treatment of diarrhoea with Saccharomyces boulardii in children with acute lower respiratory tract infections |
| Q41468202 | Probiotic prophylaxis to prevent ventilator associated pneumonia (VAP) in children on mechanical ventilation: an open-label randomized controlled trial. |
| Q38103761 | Probiotics and Prebiotics in Infants and Children |
| Q42215183 | Probiotics during weaning: a follow-up study on effects on body composition and metabolic markers at school age. |
| Q33468892 | Probiotics for the Prevention of Pediatric Antibiotic-Associated Diarrhea |
| Q41850934 | Probiotics for the prevention of Clostridium difficile |
| Q24202700 | Probiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children |
| Q46236620 | Probiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children. |
| Q91644124 | Probiotics for the prevention of pediatric antibiotic-associated diarrhea |
| Q24186991 | Probiotics for the prevention of pediatric antibiotic-associated diarrhea |
| Q35278680 | Probiotics to counteract biofilm-associated infections: promising and conflicting data |
| Q38038697 | Probiotics, prebiotics infant formula use in preterm or low birth weight infants: a systematic review |
| Q46103426 | Probiotics: current evidences and new perspectives |
| Q89691882 | Reducing C. difficile in children: An agent-based modeling approach to evaluate intervention effectiveness |
| Q34413913 | Respiratory viral infections in children with asthma: do they matter and can we prevent them? |
| Q38766816 | Safety of Bifidobacterium animalis Subsp. Lactis (B. lactis) Strain BB-12-Supplemented Yogurt in Healthy Children |
| Q34667396 | Safety of Bifidobacterium animalis subsp. lactis (B. lactis) strain BB-12-supplemented yogurt in healthy adults on antibiotics: a phase I safety study |
| Q47153405 | Scientific Opinion on the substantiation of a health claim related toLactobacillus rhamnosusGG and maintenance of normal defecation during antibiotic treatment pursuant to Article 13(5) of Regulation (EC) No 1924/2006 |
| Q57114716 | Short and long-term effects of a synbiotic on clinical signs, the fecal microbiome, and metabolomic profiles in healthy research cats receiving clindamycin: a randomized, controlled trial |
| Q41004993 | Should pediatric infectious diseases physicians be proponents of probiotics? |
| Q38433362 | Systematic review with meta-analysis: Saccharomyces boulardii supplementation and eradication of Helicobacter pylori infection. |
| Q35866469 | The Infant Microbiome: Implications for Infant Health and Neurocognitive Development |
| Q38055820 | The Role of Probiotics in the Prevention and Treatment of Antibiotic-Associated Diarrhea and Clostridium Difficile Colitis |
| Q28075770 | The Significance of the Enteric Microbiome on the Development of Childhood Disease: A Review of Prebiotic and Probiotic Therapies in Disorders of Childhood |
| Q26748672 | The effects of antibiotics on the microbiome throughout development and alternative approaches for therapeutic modulation |
| Q33754027 | The interplay between host immune cells and gut microbiota in chronic inflammatory diseases |
| Q38174603 | The role of probiotics and prebiotics in inducing gut immunity. |
| Q38942589 | The safety and feasibility of probiotics in children and adolescents undergoing hematopoietic cell transplantation |
| Q90300184 | Use of design of experiments to optimize the production of microbial probiotic biofilms |
| Q34854716 | Which CAM modalities are worth considering? |
| Q38017544 | Why the European Food Safety Authority was right to reject health claims for probiotics |
| Q53632775 | Yoghurt and probiotic bacteria in dietary guidelines of the member states of the European Union |
Search more.